1. Home
  2. VET vs WVE Comparison

VET vs WVE Comparison

Compare VET & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vermilion Energy Inc.

VET

Vermilion Energy Inc.

HOLD

Current Price

$10.18

Market Cap

1.4B

Sector

Energy

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$5.81

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VET
WVE
Founded
1994
2012
Country
Canada
Singapore
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
2004
2015

Fundamental Metrics

Financial Performance
Metric
VET
WVE
Price
$10.18
$5.81
Analyst Decision
Hold
Strong Buy
Analyst Count
1
16
Target Price
$15.00
$29.81
AVG Volume (30 Days)
1.2M
3.1M
Earning Date
05-06-2026
04-28-2026
Dividend Yield
2.84%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,704,000.00
Revenue This Year
$14.07
N/A
Revenue Next Year
$3.40
$85.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
149.43
52 Week Low
$7.00
$5.02
52 Week High
$14.82
$21.73

Technical Indicators

Market Signals
Indicator
VET
WVE
Relative Strength Index (RSI) 53.93 44.38
Support Level $9.66 $5.48
Resistance Level $10.92 $6.48
Average True Range (ATR) 0.32 0.30
MACD 0.17 -0.02
Stochastic Oscillator 100.00 30.93

Price Performance

Historical Comparison
VET
WVE

About VET Vermilion Energy Inc.

Vermilion Energy Inc is an international oil and gas-producing company. The company engages in full-cycle exploration and production programs that focus on the acquisition, exploration, and development of liquids-rich natural gas in Canada and conventional natural gas in Europe while optimizing low-decline oil assets. Its operating segments are: Canada, France, Netherlands, Germany, Ireland, Australia, and CEE, each representing the oil and gas exploration operations at its assets located in these regions. The company mainly derives revenue from the production and sale of petroleum and natural gas. The majority of its revenue is generated from Canada, where the company's operations are mainly focused on the Deep Basin trend in the West Pembina region of Alberta and on the Mica property.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: